Officials from AdipoLABs and Cyberjaya University are taking a commemorative photo after signing an MOU for academic cooperation on pain and cancer treatment research/Photo provided by AdipoLABs
AdipoLABs (CEO Han Sung-ho), a developer of high-frequency-based hyperthermia cancer treatment medical devices, recently signed an MOU (business agreement) with Malaysia's University of Cyberjaya (UOC) to strengthen academic and research cooperation.
Valley’. It is a science complex located in the administrative city of Putraya, about 50km away from the capital Kuala Lumpur. Cyberjaya University located here and the Malaysian branch of Adipo LABs have maintained a cooperative relationship, and they now have signed an MOU on joint research and clinical trials to advance into Asia together.
Attending the signing
ceremony were Han Sung-ho, CEO of AdipoLABs Korea, and the company's Dr. Yoo
Seung-mo, Dr. Jang-sang Woo, team leader Han Ye-eun(Grace), and team leader Yoo
Seong-cheol. From Cyberjaya University, Vice President (Zabidi Azhar Mohd
Hussin) and research professors came out. Both sides decided to use this MOU as
an opportunity to strengthen academics and research based on pain treatment and
cancer treatment research and carry out various collaborative activities.
In addition, both sides decided
to maintain a cooperative system in the fields of allied health, business, IT,
and psychology in addition to the medical field. For example, Cyberjaya
operates academic programs in which professors and students can directly
participate.
Zabidi Azhar Mohd Hussin,
Vice Chancellor of Cyberjaya University, said, "We are grateful for
AdipoLABs' cooperation," and added, "We look forward to a partnership
that will be of great help in medical advancement."
Han Sung-ho, CEO of
AdipoLABs, said, “We will strive to provide good academic research
opportunities to professors and students,” and added, “Let’s promote
cooperation by taking advantage of each other’s strengths.”
Meanwhile, AdipoLABs
decided to invite Cyberjaya University professors to the 'International Medical
Sharing Conference' to be held at Seoul St. Mary's Hospital on April 28-29th.
This event is hosted by IVRA (International Virus Research Association) and the
Korean Society of Thermal Medicine and is an opportunity to share clinical
cases from domestic and foreign cancer treatment experts. What is special about
the specific event is that cancer patients, their families, and medical staff
can all attend as well.
